期刊
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
卷 140, 期 8, 页码 2781-2784出版社
AMER CHEMICAL SOC
DOI: 10.1021/jacs.7b13660
关键词
-
资金
- National Institutes of Health [U01 R01 GM 098033]
- NIH [NIH R01AG04873]
- NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM098033] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE ON AGING [R01AG048793] Funding Source: NIH RePORTER
Cross-seeding of misfolded amyloid proteins is postulated to induce cross-species infection of prion diseases. In sporadic Alzheimer's disease (AD), misfolding of 42-residue beta-amyloid (A beta) is widely considered to trigger amyloid plaque deposition. Despite increasing evidence that misfolded A beta mimics prions, interactions of misfolded 42-residue A beta 42 with more abundant 40-residue A beta 40 in AD are elusive. This study presents in vitro evidence that a heterozygous E22G pathogenic (Arctic) mutation of A beta 40 can enhance misfolding of A beta via cross-seeding from wild-type (WT) A beta 42 fibril. Thioflavin T (ThT) fluorescence analysis suggested that misfolding of E22G A beta 40 was enhanced by adding 5% (w/w) WT A beta 42 fibril as seed, whereas WT A beta 40 was unaffected by A beta 42 fibril seed. C-13 SSNMR analysis revealed that such cross-seeding prompted formation of E22G A beta 40 fibril that structurally mimics the seed A beta 42 fibril, suggesting unexpected cross talk of A beta isoforms that potentially promotes early onset of AD. The SSNMR approach is likely applicable to elucidate structural details of heterogeneous amyloid fibrils produced in cross-seeding for amyloids linked to neurodegenerative diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据